Results 361 to 370 of about 191,621 (404)
Some of the next articles are maybe not open access.

Randomized trial of vonoprazan‐based versus proton‐pump inhibitor‐based third‐line triple therapy with sitafloxacin for Helicobacter pylori

Journal of Gastroenterology and Hepatology, 2018
This was a prospective, randomized trial of the efficacy of vonoprazan‐based and proton‐pump inhibitor‐based 7‐day triple regimens with amoxicillin and sitafloxacin as a third‐line therapy for eradicating Helicobacter pylori after failure of ...
Soichiro Sue   +6 more
semanticscholar   +1 more source

Proton pump inhibitors

BMJ, 2023
Danny, Jenkins, Ines, Modolell
openaire   +2 more sources

Lansoprazole: A Proton Pump Inhibitor

Annals of Pharmacotherapy, 1996
OBJECTIVE: To summarize the published data on lansoprazole, a proton pump inhibitor approved by the Food and Drug Administration for use in the treatment of duodenal ulcer, erosive esophagitis, and pathologic hypersecretory conditions (e.g., Zollinger-Ellison syndrome).
openaire   +2 more sources

An Overview of Proton Pump Inhibitors

Gastroenterology Nursing, 2003
Proton pump inhibitors are the standard of treatment for acid-related disorders. These disorders include gastroesophageal reflux disease and its complications (i.e., erosive esophagitis and Barrett's esophagus), peptic ulcer disease, Zollinger-Ellison syndrome, and idiopathic hypersecretion.
openaire   +2 more sources

Saliva Pepsin Detection and Proton Pump Inhibitor Response in Suspected Laryngopharyngeal Reflux

The Laryngoscope, 2018
To evaluate the prediction value of saliva pepsin detection for an 8‐week proton pump inhibitor (PPI) response in patients with a Reflux Symptoms Index (RSI) score ≥13, which indicates possible laryngopharyngeal reflux.
Ching‐Ping Wang   +6 more
semanticscholar   +1 more source

Deprescribing Proton Pump Inhibitors

JAMA Internal Medicine, 2020
Jacob E, Kurlander   +2 more
openaire   +2 more sources

Proton Pump Inhibitors and Mortality

Gastroenterology, 2023
Helge L. Waldum, Reidar Fossmark
openaire   +2 more sources

The broadening scope of oral mucositis and oral ulcerative mucosal toxicities of anticancer therapies

Ca-A Cancer Journal for Clinicians, 2022
Sharon Elad, Noam Yarom, Yehuda Zadik
exaly  

Proton pump inhibitors

Medical Journal of Australia, 1998
openaire   +2 more sources

Home - About - Disclaimer - Privacy